Thursday, December 8, 2016  |  Volume 8 / Number 25  |  A Production of the BioProcessing Journal
Sony FX500
Career Development
ISBioTech 7th Spring Meeting
Cell & Gene Therapy World
Immunotherapy World
January 18–20, 2017
Miami, Florida USA
CMC Strategy Forum
January 23, 2017
January 24–26, 2017
Washington, DC USA
20th Annual Meeting
May 10–13, 2017
Washington, DC USA
25th ESACT Meeting
25th ESACT Meeting
May 14–17, 2017
Lausanne, Switzerland
Techno-Blast Masthead
Unstained fibroblasts derived from human skin. Total magnification is 100X.
Courtesy of Coriell Institute for Medical Research
Suggested Reading
Gamma Irradiation of Frozen Animal Serum:
Dose Mapping for Irradiation Process Validation
By Bart Croonenborghs, PhD, Sterigenics International;
Andy Pratt, Lorraine Bone, and Mara Senescu
Open Access
Sponsored Link
Lonza EasyAccess ADC
Managing the complexities of supply chain and safety are critical to the success of antibody drug conjugates (ADCs). Let us be your trusted partner. We offer superior services for your antibody drug conjugates:
R&D safety labs for process development and toxicology batches (5 mg – 50 g)
GMP suites for clinical (50 g – 250 g) and commercial supply (500 g – 3 kg)
Complete analytical development packages with mAb/ADC harmonization
Quick turnaround of R&D projects, toxicology batches and Phase I GMP production
Dedicated staff and over 100 GMP clinical ADC batches released with very high success rates
Lonza offers superior services for your antibody drug conjugates. Take advantage of the best characteristics of mAbs and cytotoxic molecules with our EasyAccess™ ADC programs.
Lonza Antibody Drug Conjugates,,
Sponsored Link
BioPlan Associates, Inc.
14th Annual Biopmarmaceutical Manufacturing Survey for 2017
Participate in the most in-depth benchmarking and analysis study on global and regional trends affecting the bioindustry. This year we’ve updated questions and added new ones! Participants will receive a FREE aggregated summary of the results; our 15 Top Trends in Biopharmaceutical Manufacturing white paper; and for each completed survey, BioPlan will donate $10 (up to $2,000 total) to global health charities. The survey takes 15-25 minutes, depending on your areas of expertise.
Contact Donnie Elizabeth Gillespie, Director, Research Projects, for more information.
BioPlan Associates, Inc., Rockville, MD 20850 USA, Phone: 1-301-921-5979
Products & Services
Revolutionary New DNA Synthesizer Could Reshape Everyday PCR Experiments
Eurofins Genomics has launched a limited beta program for its new DNA synthesis service, ideal for scientists who need small quantities of very high-quality starting material for routine molecular and synthetic biology applications. The service is based on the company's revolutionary new DNA synthesizer that rapidly generates high-fidelity, QC-verified oligos.
Researchers in academic, clinical, diagnostic, agbio, biotech, and pharmaceutical laboratories routinely develop PCR-based assays that require small quantities of primers — chemically synthesized strands of custom DNA. Gene synthesis and related synthetic biology projects also require very small quantities of high-quality oligonucleotides. By delivering only the volumes needed, Eurofins Genomics can drastically reduce users' costs while meeting the high quality and fast turnaround times they expect.

Earlier this year, Eurofins Genomics moved its North American headquarters to Louisville and built a new state-of-the art lab to improve service and turn-around times. When the beta program is complete, the new synthesis service will launch in early 2017 with next-day delivery. For more information, please visit
DNA synthesis service
Career Development
ISBioTech 4th Fall Meeting
BioProcess Cuba
BPJ Publishing
Now Offers Open Access
BioProcessing Journal BioProcessing Journal
Economize by combining Techno-Blast and BioProcessing Journal advertising into one package.

Request a media kit today!
Did a colleague forward this to you? Subscribe here. While we'd hate to see you go, you can unsubscribe instantly.